NDAORALTABLET
Approved
May 2013
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
MINASTRIN 24 FE (ethinyl estradiol; norethindrone acetate) by Dr. Reddy's Laboratories. Approved for pregnancy. First approved in 2013.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MINASTRIN 24 FE is an oral combined hormonal contraceptive containing ethinyl estradiol and norethindrone acetate, indicated for prevention of pregnancy. The product is a small-molecule tablet formulation that works by suppressing ovulation through estrogen and progestin activity. It is a conventional oral contraceptive in the peak lifecycle stage, approved since 2013.
$0.029BPart D
PeakMINASTRIN 24 FE is in peak lifecycle with modest Part D utilization ($29K, 72 claims in 2023), suggesting a stable but niche position within a crowded contraceptive market with limited team expansion opportunity.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Career Relevance
MINASTRIN 24 FE is a mature, peak-lifecycle product with modest commercial scale and no linked job openings, offering limited career growth and primarily defensive market management responsibilities. Professionals joining this franchise should expect focus on cost-containment, competitor response, and potential lifecycle extension strategies rather than aggressive growth initiatives.
Brand Manager
Worked on MINASTRIN 24 FE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.